Immune to Cancer: The CRI Blog

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

Partner Spotlight: Rafael Amado, Adaptimmune

July 11, 2018Brian Brewer
We introduce you to Rafael Amado, M.D., chief medical officer at Adaptimmune, a leader in T cell receptor (TCR) cancer immunotherapy.

Read More

Filter by:

*Immunotherapy results may vary from patient to patient.